SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022659
Filing Date
2024-02-29
Accepted
2024-02-29 08:05:00
Documents
76
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrca-20231231.htm   iXBRL 10-K 2268574
2 EX-10.21 vrca-ex10_21.htm EX-10.21 25755
3 EX-10.27 vrca-ex10_27.htm EX-10.27 74761
4 EX-10.28 vrca-ex10_28.htm EX-10.28 69935
5 EX-23.1 vrca-ex23_1.htm EX-23.1 4232
6 EX-31.1 vrca-ex31_1.htm EX-31.1 11748
7 EX-31.2 vrca-ex31_2.htm EX-31.2 12142
8 EX-32.1 vrca-ex32_1.htm EX-32.1 10266
9 EX- 97 vrca-ex97.htm EX-97 52121
10 GRAPHIC img254478865_0.jpg GRAPHIC 77288
  Complete submission text file 0000950170-24-022659.txt   9454903

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vrca-20231231.xsd EX-101.SCH 1538758
78 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20231231_htm.xml XML 1239585
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38529 | Film No.: 24698975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)